I can't speak for him of course...but,
I asked Dew to take a look at it and allow me to post it on the Biotech value board only if he agreed.
I suspect it was due to the company's lack of debt, lack of dilution, and promising partnership with Sysmex that he made the exception, but you would have to ask him directly to know for certain.
Understand completely the concern of not having a good board like Biotech Value board, (or the $heff board, which I also enjoy), turn into a pumping ground for POS junk penny stocks that have little or no promise. I think the article was fact-based with links to SEC filings, Sysmex deal, etc. and not so much "pump"- which probably helped.